Invokana litigation
Litigation alleged that the diabetes drug Invokana carried elevated risks of lower-limb amputation and diabetic ketoacidosis that patients learned about too late.
Free case review
What the litigation alleged
In 2017 the FDA required a boxed warning after clinical trials showed canagliflozin roughly doubled the risk of lower-limb amputations. The litigation alleged the manufacturer promoted the drug aggressively while those signals accumulated.
Injuries named in the litigation
- Toe, foot, or leg amputation
- Diabetic ketoacidosis
- Acute kidney injury
- Serious urinary tract infections
Who may qualify
If you took Invokana and suffered an amputation, ketoacidosis requiring hospitalization, or serious kidney injury, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.